RedHill Biopharma Ltd 20-F for FY2023
RedHill Biopharma Ltd. (RDHL)
20-F
2024-04-08
For: 2023-12-31
View Original
Added on
April 07, 2026
About this 20-F
RedHill Biopharma Ltd filed this 20-F on April 8, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $6.53M
- down 89.4% from $61.8M a year earlier
- Net income
- $23.92M
- compared with a net loss of $71.67M a year earlier
- Diluted EPS
- $0.01
- compared with -$0.12 a year earlier